chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left thigh (injection site) with redness and swelling from thigh to knee. No warmth non tender to touch. Walks with mild limp. Motrin for pain.
Information has been received from an office manager (health professional) referring to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored ROTATEQ (lot # K011947, expiration date 07-JUN-2016, strength and dose were unknown) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
She experienced immediate pain at site followed by difficulty with range of motion of right shoulder and arm, pain radiated to top of shoulder area. After 2-3 weeks of pain and decreased range of motion, she sought care at Urgent Care. Urgent Care provider instructed her to apply ice to the area, take MOTRIN and prescribed range of motion exercises. She followed instructions and pain persisted. She saw her primary care provider and x-ray of right shoulder ordered. Normal findings. Returned to primary care provider on 10/27/2017 and pain was getting better. Primary care provider referred to physical therapy and she went to one session today, 10/30/2017. Range of motion exercises provided and shoulder iced. Pain has decreased and range of motion is better.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 03-NOV-2012 at 09:49, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
About 5 minutes after vaccination, patient complained of dizziness/spinning. It continued for several minutes when he became syncopal and briefly unresponsive. Heart rate 40. Glucose 103. BP 108/60. Respiratory rate 20 and sonorous. Placed on monitor which showed sinus bradycardia. 20 minutes after vaccination, patient recovering and able to talk but diaphoretic and weak. Taken to ER by paramedics.
Pt recv vax on 1/6/99; on same day pt exp constant crying x 24 hr, twitching, decreased appetite
Vaccine Administered at Inappropriate Site; fever; Chills; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 47JA3, expiry date 12th May 2020) for prophylaxis.   On 17th April 2019, the patient received the 2nd dose of Shingrix (subcutaneous) .5 ml. In April 2019, less than a day after receiving Shingrix, the patient experienced fever and chills. On 17th April 2019, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the fever, chills and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix subcutaneously instead of intramuscularly in left arm, which led to vaccine administered at inappropriate site. The patient was complaining of fever and chills. The patient did not consent to follow up.
after vaccines mom bundled child up and placed in car seat, so approx 5 min after vaccine child's face only broke out(blotchy & warm to touch)had child wait for 20 min, blotchness subsided with no resp. distress.  Initial report received on 29 March 2010 from a healthcare professional.  This case is linked to case 2010-01875.  A 4 month-old male patient received the following vaccine on 01 February 2010: an intramuscular injection in the right leg of PENTACEL (lot number reported as C3404AA/C357AA); an intramuscular injection in the right leg of PNE-IMUNE, (Wyeth, lot number E28211); and an oral dose of ROTATEQ, (Merck, lot number 1442Y).  Five minutes after vaccination the patient's face became blotchy and was warm to the touch.  The patient remained in the healthcare professional's office for 20 minutes and the symptoms subsided.  No respiratory distress was noted.  The patient also experienced a bloody bowel movement.  The onset date was not reported.  No medical history was noted and the patient was not ill at the time of vaccination.  The patient recovered.  List of documents held by sender: none.
Starting at the end of March 2021 I began to have a menstrual cycle that lasted for over two weeks. At that time I went to my OBGYN, he ordered a internal pelvic ultrasound and blood work. Nothing out of the ordinary was found. Continued to bleed for an additional two weeks, primary OBGYN was going to schedule a D&C.   Beginning April of 2021 experiencing extreme fatigue, head fog and irritability. Have been to OBGYN, Primary doctor and chiropractor on multiple occasions to try to pin point the cause. As of 7/22/2022 nothing has been found "abnormal" via blood work.
Booster/3rd shot on 11/19/2021. Itchy spot at watchband line started 12/1/2021. Scalp itching and redness in sweat areas on 12/2/21. What appeared to be bug bites on arm and elbow morning of 12/3/21. Lips began swelling by noon on 12/3/21.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Nurse). The reporter is the patient.  A 21-year-old female patient (not pregnant) received BNT162b2 (Pfizer-BioNTech COVID-19), on 20Jan2021 as dose 2, single (Batch/Lot number: unknown) at the age of 20 years, in left arm and on 20Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 21 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Moderate asthma" (unspecified if ongoing); "POTs"(Postural orthostatic tachycardia syndrome) (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid to treat drug ineffective, covid-19. Treatment start date 22Jun2022, treatment stop date 26Jun2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.
day of vax pt c/o dizziness, h/a in back of head, tingling in lt arm going down to fingers & c/o feeling strange. 7/21 c/o muscle twitching lt face & lt leg.
SWELLING OF THROAT, ITCHY, TROUBLE OF BREATHS, TINGLING IN FINGERS
Mother called 8 days after DTap was given in right thigh to c/o swollen, hot to touch area at site - unrelieved by TYLENOL for age referred to PCP.
This spontaneous report was received from a physician via a company representative referring to a 17 year old male patient. The patient passed out at this doctor's office in the past when he had blood drawn. Information about concomitant medication and pertinent medical history was unknown by the reporter. On 22-OCT-2018, the patient was vaccinated with GARDASIL 9 (strength, dose,  lot # and expiration date were not reported) intramuscularly(IM) for prophylaxis. On the same day after the vaccination, the patient experienced a syncopal episode. The patient was kept at the doctor's office until he recovered. There was no treatment given for the event and not seek medical attention. Information about lab diagnostics/studies was unknown by the reporter. The causality assessment was not provided.
A report has been received from a Health Professional concerning a female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. The accidental administration of expired FLUMIST Quadrivalent to four patients was reported by the health professional. The outcome of the event of accidentally administered expired FLUMIST Quadrivalent to four patients is unknown. The report was considered to be non-serious.
WITHIN 6-8HRS AFTER BOOSTER MY VISION IN LEFT EYE GOT BLURY, EAR PRESSURE IN LEFT EAR, WHOSIE/DIZZY MAINLY ON LEFT SIDE OF BODY. SEE OTHER PAGE FOR REACTION AT OLD TREATMENTS ETC! IN ADDITION TO MY DRASTIC VISION CHANGES IN MY LEFT EYE I CONTINUE THRU THIS LETTER TO HAVE LEFT EAR PRESSURE, LEFT SIDE BALANCE ISSUES AS WELL EXAGERATED PAIN IN MY LEFT SHOULDER DUE TO A BROKEN HUMERUS THAT HAD TO BE A PRIORITY AT PHYSICAL THERAPY THAT WAS WELL MANAGED FOR ALMOST 1 1/2 YEARS BEFORE THIS BOOSTER DAMAGE ON 4/14/22. ALSO MY LOWER BACK INJURIES BECAME PAIN FILLED LIKE YEARS BACK AFTER THIS LAST PFIZER BOOSER 4/14/22. MY LEFT KNEE NOW HURTS AFTER I HAD INJECTION 2 WEEKS AGO FOR IMMUNE IMPROVEMENTS AS HAD JULY 31ST. AT THE ONSET OF MY LEFT EYE VISION CHANGES AKA BLURY I ALSO HAD DEVELOPED PINS + NEEDLES IN MY LEFT EYE THE WEEK AFTER THAT 4/14/22 BOOSTER. THE PINS N NEEDLES EFFECT HAS GONE AWAY 99% OF TIME POSSIBLY DUE TO 4 B-12 INJECTIONS FOR NERVE DAMAGE FROM BOOSTER.
Patient was given 2nd dose of pfizer, walked out of room and sat in chair for observation. Within minutes patient fell out of chair and fell to the floor.  Pharmacist ran to assist patient and within seconds patient came to.  911 was called.  Patient sat back up in chair and starting sweating profusely.  Ice pack was  applied to back of neck.  Patient stated that he was having  "head rushes" .  Paramedics arrived and checked the patient out, ran vitals and told patient he was ok to leave as long as he wasnt driving. Patient family member drove him home.  Paramedics left and patient stayed for another 15 minutes and then left
Mild headaches that started the afternoon of the second vaccine. I took tylenol the first few afternoons, but discontinued daytime use and took the tylenol every night at bedtime. Headache is not continuous, but does occur for several hours at sometime during the day.
I had taken Benadryl prior to the shot as I had the two week delayed reaction in the injected arm. I spoke with my doctor about this and she was not concerned as many had reported that. I was at home later that night and realized I could not feel my  lips. My chest started to tighten. I spoke to an on call DR who advised me to take 50mg  more of Benadryl and to carry my epi in case I began having shortness of breath. I followed those direction. I did not require steroid treatment and the Benadryl was enough to get the reaction under control. I did experience vertigo the following two days with flu like symptoms. I have never had vertigo prior to the shot. I now have it 2-3 times a week when getting up from a laying down position. My period have also been a little irregular and more painful. I am unsure if this is related.
Severe dizziness, unable to stand for almost 4 hours. Ended up collapsing due to dizziness and momentary loss of consciousness due to fall and dizziness
Pt recvd vax 10JUN92 1 wk later began gaining weight; 11JUL92 went to ER w/obvious wt gain & fluid retention abdomen & scrotum; also had elevated BP & hematuria 13JUL92 hosp-adm; kidney biopsey done;
Pt developed rash on face, torso and extremities within 10 minutes of vaccine administration. Pt was given BENADRYL and monitored in office for 20-25 minutes. Rash improved.
Pt got a large reddened area with raised rash at injection site. 11 days after injection.
Dizziness  Shortness of breath  Narrative:  Employee reported being "short of breath" approximately 10 minutes after receiving second dose of Moderna. Respirations were even, nonlabored and she was able to speak without difficulty. SPO2 was 100% on room air. She states she has an inhaler at her work station and would use it upon her return after monitoring period was complete. She states she did use her inhaler but states she is still short of breath and needs to go home to use her nebulizer. She was  instructed to contact her PCP for further guidance and to report to the nearest ER if symptoms worsened. She verbalized understanding.
Systemic: Blood Disorder  (diagnosed by MD)-Severe, Additional Details: Patient passed away on 4/23/21 and had blood clots throughout body. Patient did not have any other symptoms that were reported. Patients family requested a VAERS report be submitted.
This literature marketed report as received from a other health professional refers to a 43 year old female patient with asthma. This is case 4 of 5 reports. Patient's medical history was not reported. On an unknown date the patient was vaccinated with PCV (manufacturer unknown) (dose and frequency unknown) in the arm. Other suspect therapy included influenza virus vaccine (manufacturer unknown). Both the vaccination were received in the same arm. The patient was also vaccinated with Tdap. The patient received an additional injection Tdap vaccine in the opposite arm. On an unknown date the patient experienced large local inflammatory reactions (erythema, oedema and warmth), rigors, fever, leucocytosis and presumed cellulitis. The patient's laboratory results included WBC 22K/microliter, and Maximum temperature 102.8 degree F. It was reported that the patient was not hospitalised. The patient sought care within 2-3 d of vaccination. Within 5-7 days, the patient experienced improvement in the skin findings and resolution of the systemic symptoms. In one patient, the local swelling and erythema at the injection site lasted about 2 weeks. No patients included in this series have received any subsequent vaccines. The outcome of large local inflammatory reactions (erythema, oedema and warmth) and presumed cellulitis was reported as recovering/resolving. The outcome of fever, leucocytosis and rigors was reported as recovered/resolved. The reporter considered the events to be not related to Influenza Virus Vaccine (manufacturer unknown). The reporter considered the events to be related to PCV (manufacturer unknown). The author stated that "the 5 patients in this series all had leukocytosis, fever and large local inflammatory reactions following influenza vaccine (manufacturer unknown) and PCV (manufacturer unknown). Based on the known side effects of PCV (manufacturer unknown), the lack of similar findings in patients who receive the influenza vaccine (manufacturer unknown) and another patient's lack of influenza vaccine (manufacturer unknown associated local symptoms we believe these reactions were due to PCV (manufacturer unknown)". This case is linked to case # 1405USA008574, 1405USA007995, 1405USA008573 and 1405USA008576 (same reporter link). Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of an unknown age and an unknown gender. The unspecified patients pertinent medical history was not reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored RECOMBIVAX HB. No adverse effects were reported. No product quality complaint (PQC) was reported. This is one of the several reports from the same reporter. Additional information has been requested.
reporting because Pfizer is recalling this lot  of Covid IMZ. for  short dating.  Expiration date was supposed to be  10/21/2022 but we received notification that it expired on 9/30/2022.  So, this IMZ was given after that
Flu; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves patient (unknown demography) who got the flu (influenza), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  The event outcome was unknown at the time of report.  There will be no information available on the batch number for this case.
Face numbing (mainly around lower region of face), heart palpitation, nausea, chills
Normal after the inj. 8 hours later, arm pain, fatigue. Next day at noon, felt anxious, heart rate 140's, extreme back pain, tachycardia. Lasted 12 hours 140 at rest. Movement 160 rate. Had chest pain. High fever 102-103.
lip tingling; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  Medical history included before having the shot, she was being anxious as described by feeling nervous, having sweaty palms, her heart was racing, couldn't listen to the lady that was administering the shot, difficulty in concentration. The patient's concomitant medications were not reported. The patient experienced lip tingling that happened momentarily and went away on its own as an adverse event. The action taken in response to the event(s) for bnt162b2 was not applicable. Because of this event, her employer won't let her have the second shot for the COVID-19 vaccine. She had an appointment with her allergist who assured her that her experience was not an anaphylactic reaction and it was not a contraindication to the vaccine. Outcome of the event was unknown.  Information on Lot/Batch number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2021 as dose 3, (booster) single at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: Patient had no Known allergies.
A little soreness in her arm; Metal taste; This is a spontaneous marketing program report from a contactable consumer or other non hcp (patient herself). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunization. The patient's medical history included Multiple sclerosis from an unknown date patient taking Immunosuppressant Ocrevus. Historical vaccination included the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunization.The patient's concomitant medications were not reported. On an unspecified date the patient experienced with A little soreness in her arm, Metal taste patient state that it was like I ate hot soup. The patient enquired about the information about the individuals with MS or taking immunosuppressants who received the vaccination. The outcome of the event Metal taste patient state that it was like I ate hot soup was not resolved and while   "A little soreness in her arm was unknown.  Information on Lot/Batch number has been requested.
Developed burning, stinging, somewhat itchy small red bumps, some a little bigger like a bug bite, rash on neck, upper and middle back, chin, ears inside around and behind ears, parts of face close to ears, nose, above mouth, between eyebrows, a few on chest, now also developing  new small red bumps that feel almost like a bee sting when they first pop out on middle lower back, lower legs and several popping out on right ring finger, upper forehead. Have what I think are 2 bug bites on stomach, two on left arm 2 on middle back and 1 on upper back. Also feel like a bug possibly in my vaginal area. I don't know for sure if those are bug bites but I was working in my yard planting a vegetable garden.   Maybe be poison ivy or something like that but not sure.  It's been 3 weeks since my first shot but CDC recommended I report what is happening just incase. I have delayed my second vaccine till next month to let this hopefully clear up.